Live Breaking News & Updates on Pentec health

Lobe Sciences Provides Company Review of 2023

12-month data confirming that L-130 is the first reported stable oral psilocin


First-in-Man clinical data demonstrates the superior PK profile of L-130


2023 sales of $1.1M for Altemia®

.

Philip-young , Lobe-sciences-ltd , Young , Lobe-sciences , Pentec-health , Sickle-cell-disease , Orphan-diseases , Exclusive-collaboration , Healthcare-conference , San-francisco , Markets ,

Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth - adhoc - Börsennachrichten

Relief Therapeutics Holding SA Key word Miscellaneous Relief Therapeutics Shifts Commercial Operations to Partnership Model Focusing on Efficient Patient Access and R&D Growth 05Dec2023 0700 CETC

Greece , United-kingdom , Portugal , Spain , Switzerland , Germany , Ecuador , Israel , Geneva , Genè , Balerna , Switzerland-general

Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth

Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cyprus , Portugal , Austria , Switzerland , Greece , Balerna , Switzerland-general , Monza , Lombardia , Italy , United-kingdom , Spain

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Geneva , Genè , Switzerland , Balerna , Switzerland-general , Ecuador , Portugal , Cyprus , Germany , Secheron , United-kingdom , Spain

Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health

Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces Extension of .

Italy , Geneva , Genè , Switzerland , Germany , Monza , Lombardia , Balerna , Switzerland-general , Swiss , Chris-wick , Zoia-pharma

Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE in the U.S. with Pentec Health

19.07.2023 - Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE in the U.S. with Pentec Health 19.07.2023 / 07:30 CET/CEST Relief Therapeutics Announces . Seite 1

Geneva , Genè , Switzerland , Jack-weinstein , Pentec-health-inc , Pentec-health , Pentech-health , Recent-pentech-health , Relief-therapeutics ,

Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health - Relief Therapeutics (OTC:RLFTF), Relief Therapeutics (OTC:RLFTY)

Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE®GENEVA, SWITZERLAND / ACCESSWIRE / July 19, 2023 / RELIEF THERAPEUTICS Holding SA

Geneva , Genè , Switzerland , Italy , Monza , Lombardia , Germany , Balerna , Switzerland-general , Swiss , Chris-wick , Zoia-pharma